Cigna: Which Healthcare Giant Fits Your Retirement Portfolio
In a turbulent 2026 market, CVS Health and Cigna are at the center of retirement portfolio debates. This piece weighs...
What Can Go Wrong Staking Stablecoins
Staking stablecoins can offer rewards, but there are risks to consider. This intro highlights potential issues and basic protections for stakers.
27,764 articlesPalantir Alex Karp Says There Was No Domestic Surveillance
Palantir CEO Alex Karp asserts there was never a domestic surveillance plan in the Anthropic-DoD dispute, detailing t...
Most Brokerages Scale Revenue, Not Profit: Hidden Costs
Loan brokerages are expanding headcount and GCI, but margins are thinning. A new industry look shows why growth often...
NVIDIA Leads Magnificent Stocks in March, Market Breathes
NVIDIA leads the Magnificent 7 in March with a 1.7% gain through Friday, while Apple and Tesla retreat as investors r...
Benchmark’s Bill Gurley: Bubble Looms Over AI Rally
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
BNB Chain Launches BNBAgent SDK for Trustless AI Agents
BNB Chain unveils the BNBAgent SDK, the first live implementation of ERC-8183, enabling trustless, autonomous AI work...
Oil Price Rises to $113.71 as Markets Rally in March 2026
Brent crude climbs to $113.71 per barrel on March 19, 2026, as traders weigh supply discipline and demand signals. He...
Billion Buyback Raising Questions About Salesforce Growth
Salesforce delivered a solid Q4 beat and announced a $50 billion buyback, but FY27 guidance disappointed investors. T...
Core Question Freshworks Investors: Buyback Versus AI Risk
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...
Cardano Price Prediction: Hard Fork Sparks Fresh Momentum
Cardano's ADA is set for a major upgrade while traders watch a tight price range. Regulatory clarity and cross-chain ...
MOS Trades Earnings While Brazil Growth Impresses Investors
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...
Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status